why choose us

First received: July 21, 2022

Clinical Trial: Effect of Postbiotic Product on Colonic Barriers in IBS

Study Status: Completed

Recruit Status: Completed

Condition: IBS - Irritable Bowel Syndrome

Study Type: Interventional


Official Title: A Postbiotic Fermented Oat Gruel May Have a Beneficial Effect on the Colonic Mucosal Barrier in Patients With Irritable Bowel Syndrome

Brief Summary: Impaired intestinal permeability and microbial dysbiosis are important pathophysiological mechanisms underlying irritable bowel syndrome (IBS). ReFerm®, also called Profermin®, is a postbiotic product of oat gruel fermented with Lactobacillus plantarum 299v. In this experimental study, we investigated whether ReFerm® has a beneficial effect on the intestinal epithelial barrier function in patients with IBS.

Read more